by | Jun 28, 2024 | Publications
Clin Exp Med. 2024 Jun 27;24(1):137. doi: 10.1007/s10238-024-01411-2. ABSTRACT Patients with multiple myeloma (MM) have an increased risk of sepsis due to underlying disease- and treatment-related immunosuppression. However, data on sepsis incidence, causative...
by | Jun 28, 2024 | Publications
Nat Rev Dis Primers. 2024 Jun 27;10(1):46. doi: 10.1038/s41572-024-00535-9. NO ABSTRACT PMID:38937486 | DOI:10.1038/s41572-024-00535-9
by | Jun 28, 2024 | Publications
Nat Rev Dis Primers. 2024 Jun 27;10(1):45. doi: 10.1038/s41572-024-00529-7. ABSTRACT Multiple myeloma (MM) is a haematological lymphoid malignancy involving tumoural plasma cells and is usually characterized by the presence of a monoclonal immunoglobulin protein. MM...
by | Jun 28, 2024 | Publications
Pathol Res Pract. 2024 Jun 17;260:155401. doi: 10.1016/j.prp.2024.155401. Online ahead of print. ABSTRACT Phosphatase and tensin homolog (PTEN), phosphatidylinositol 3-kinase (PI3K), and protein kinase B (Akt) signaling pathways contribute to the development of...
by | Jun 28, 2024 | Publications
Lancet Haematol. 2024 Jul;11(7):e473-e475. doi: 10.1016/S2352-3026(24)00168-6. NO ABSTRACT PMID:38937020 | DOI:10.1016/S2352-3026(24)00168-6
by | Jun 27, 2024 | Publications
Cancer. 2024 Jun 27. doi: 10.1002/cncr.35464. Online ahead of print. NO ABSTRACT PMID:38935525 | DOI:10.1002/cncr.35464
